Currently, women are surviving longer with advanced ovarian cancer and treatment aims to improve quality of life along with increasing survival.Lawrence, AlexandraSt. Bartholomew’s NHS Trust, WhitechapelDilley, JamesSt. Bartholomew’s NHS Trust, Whitechapel...
The impact of subspecialty training on the management of advanced ovarian cancer. Gynecol Oncol. 1992;47(2):203–9.PubMedView Article 8.Elattar A, Bryant A, Winter-Roach BA, Hatem M, Naik R. Optimal primary surgical treatment for advanced epithelial ovarian cancer. Cochrane Database Syst ...
Radiocolloids in the treatment of ovarian cancer Though radiocolloids have been used for over twenty years in the treatment of ovarian cancer, no comprehensive review of the literature exists. This review... ROSENSHEIN,B Neil,LEICHNER,... - 《Obstetrical & Gynecological Survey》...
About a third of patients with ovarian cancer present with localized disease; despite surgical resection, up to half the tumors recur. Since it has not been established whether adjuvant treatment can benefit such patients, we conducted two prospective, randomized national cooperative trials of adjuvant...
Background: Ovarian cancer is the disease with worst prognosis in oncogynecology. Early detection is difficult and late diagnosis is the most common. Patients and methods: For a 25-year period (1982-2006) 2016 patients with ovarian cancer were treated in our clinic. Results: 85 patients were ...
Approximately 20% of women with advanced-stage ovarian cancer survive beyond 12 years after treatment and are effectively cured. Initial therapy for ovarian cancer comprises surgery and chemotherapy, and is given with the goal of eradicating as many cancer cells as possible. Indeed, the three phases...
(95% CI: 0.31-0.47) less likely to receive surgery (pConclusion: While racial/ethnic disparity in ovarian cancer diagnosis and treatment is not driven by contextual-level factors examined in this study, observed geographic variation in surgery treatment warrants further attention in disparities ...
Ovarian preservation and staging in reproductive-age endometrial cancer patients may be possible in young women with early stage low grade endometrial cancer but BSO should be strongly considered as part of the surgical treatment.doi... CE Richter,B Qian,M Martel,... - 《Gynecologic Oncology》 ...
Allarity Therapeutics discontinues Phase 2 trial of stenoparib for ovarian cancer, showing clear clinical benefit.
ovarian cancer: 1) referral to an expert center, with a rate of optimal primary cytoreduction of 75% and utilization of combined intraperitoneal and intravenous adjuvant chemotherapy, and 2) referral to a less experienced center, with a rate of optimal primary cytoreduction of 25% and adjuvant ...